Humana upgraded to Outperform after strong Q2 2026 results

Evercore ISI raised its view after adjusted earnings of $7.61 per share and $40.9 billion in revenue both topped analyst expectations, helped by 20.7% growth in Medicare Advantage.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.